4.7 Article

Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations

期刊

FRONTIERS IN PHARMACOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.636650

关键词

pharmacogenenomics and personalized medicine; prescription drug; tool; pharmacogenetic; decision-making

资金

  1. University of Calgary Cumming School of Medicine
  2. Alberta Innovates Strategic Research Project [G2018000868]
  3. Alberta Children's Hospital Research Institute

向作者/读者索取更多资源

Pharmacogenomic (PGx) testing is increasingly used in clinics and the commercial industry, but not all tests have consistent standards for translating results into prescribing recommendations. Sequence2Script is a web-based tool designed to assist users in efficiently translating PGx testing results into evidence-based prescribing recommendations. This tool supports 97 gene-drug pairs and allows users to adjust recommendations, generating a clinical report summarizing patient genotype and prescribing recommendations. The hope is that Sequence2Script will help standardize the use of PGx testing results and reduce barriers to implementation in practice.
Pharmacogenomic (PGx) testing has emerged as an effective strategy for informing drug selection and dosing. This has led to an increase in the use of PGx testing in the clinic and has catalyzed the emergence of a burgeoning commercial PGx testing industry. However, not all PGx tests are equivalent in their approach to translating testing results into prescribing recommendations, due to an absence of regulatory standards. As such, those generating and using PGx data require tools for ensuring the prescribing recommendations they are provided align with current peer-reviewed PGx-based prescribing guidelines developed by expert groups or approved product labels. Herein, we present Sequence2Script (sequence2script.com ), a simple, free, and transparent webbased tool to assist in the efficient translation of PGx testing results into evidence-based prescribing recommendations. The tool was designed with a wide-range of user groups (e. g., healthcare providers, laboratory staff, researchers) in mind. The tool supports 97 gene-drug pairs with evidence-based prescribing guidelines, allows users to adjust recommendations for concomitant inhibitors and inducers, and generates a clinical report summarizing the patient's genotype, inferred phenotype, phenoconverted phenotype (if applicable), and corresponding prescribing recommendations. In this paper, we describe each of the tool's features, provide use case examples, and discuss limitations of and future development plans for the tool. Although we recognize that Sequecnce2Script may not meet the needs of every user, the hope is that this novel tool will facilitate more standardized use of PGx testing results and reduce barriers to implementing these results into practice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据